摘要
目的:探讨表没食子儿茶素没食子酸酯[(-)epigallocatechin gallate,EGCG]对人成淋巴细胞株错配修复基因hMLH1和hMSH2 mRNA表达水平的影响。方法:将正常人成淋巴细胞株GM12593和乳腺癌患者成淋巴细胞株GM13705分别置于含有0、5、10、20μmol/LEGCG的RPMI-1640中进行6d干预培养后,采用实时荧光定量PCR(FQ-PCR)技术检测干预前后错配修复基因hMLH1和hMSH2 mRNA表达水平的变化。结果:经20μmol/LEGCG干预培养6d后,GM12593细胞hMLH1与hMSH2 mRNA表达水平均显著高于其他浓度组(P均<0.05),且显著高于同等浓度时GM13705细胞中上述2个基因的表达水平(P<0.05);EGCG对GM13705目标基因的表达无显著影响(P>0.05)。结论:EGCG具有上调正常人成淋巴细胞株hMLH1与hMSH2 mRNA表达水平的潜力,可能通过增加错配修复起始复合物的数量,来帮助错配修复机制的启动,维护基因组的稳定性。
OBJECTIVE: To investigate the effect of (-) epigallocatechin gallate(EGCG) on mRNA expressions of hMLH1 and hMSH2 in human lymphoblast cell lines. METHODS: Total RNA was isolated from GM12593 and GM13705 ceils treated with EGCG(0, 5, 10, 20 μmol/L) for 6 days. Real-time fluorecence quantification PCR(FQ-PCR) was conducted to measure the mRNA expression levels of hMLH1 and hMSH2. RESULTS: The mRNA expressions of hMLH! and hMSH2 significantly increased at 20 μmol/L EGCG in GM12593 cells, and were significantly higher than equal concentrations in GM 13705 cells. The effect of EGCG on expressions of target genes were insignificant in GM13705 ceils. CONCLUSION: EGCG had the potential to up-regulate the expressions of hMLH1 and hMSH2, contributed to the promotion of mismatch repair and maintaining genomic stability in normal human lymphoblast cell line GM12593.
出处
《癌变.畸变.突变》
CAS
CSCD
2013年第4期276-279,共4页
Carcinogenesis,Teratogenesis & Mutagenesis
基金
国家自然科学基金(30960166
31260268)
联合基因生物医药有限公司合作项目
云南省科技项目(2010ZC065)